4-[4-(4-methoxyphenyl)-5-({[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}sulfanyl)-4H-1,2,4-triazol-3-yl]pyridine

InChIKey	`KRIKILRRJCIWNB-UHFFFAOYSA-N`
Compound Name	4-[4-(4-methoxyphenyl)-5-({[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}sulfanyl)-4H-1,2,4-triazol-3-yl]pyridine
Canonical SMILES	`COc1ccc(-n2c(SCc3nc(-c4ccc(C)cc4)no3)nnc2-c2ccncc2)cc1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	5
Pfam Stratification	Cross-Family
Avg pChEMBL	6.32
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
Q06520	SULT2A1	Homo sapiens	Human	PF00685	7.3	IC50	ChEMBL;BindingDB
Q9H2K2	TNKS2	Homo sapiens	Human	PF00023 PF12796 PF13637 PF00644 PF07647	6.2	IC50	ChEMBL;BindingDB
Q13285	NR5A1	Homo sapiens	Human	PF00104 PF00105	6.1	IC50	ChEMBL;BindingDB
O95271	TNKS	Homo sapiens	Human	PF00023 PF12796 PF00644 PF07647	6.0	IC50	ChEMBL
P11712	CYP2C9	Homo sapiens	Human	PF00067	6.0	IC50	ChEMBL;BindingDB